Jiangsu Zhongbang Pharmaceutical Co Ltd

About Jiangsu Zhongbang Pharmaceutical Co Ltd

Jiangsu Zhongbang Pharmaceutical Co. Ltd. has been founded in 2001. As a high-tech enterprise, Zhongbang focuses on developing and producing pharmaceutical intermediates, APIs and finished products. The registered capital of Zhongbang is $1.26 billion and total area is 100,000 m2.

Zhongbang concentrates on the production technique of proton pump inhibitors “Prazole”, anti-hypertension “Sartan” and anticoagulants “Xaban” for more than 15 years. 

  • CN
  • 2015
    On CPHI since
  • 2
  • 250 - 499
Company types
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Jiangsu Zhongbang Pharmaceutical Co Ltd (5)